Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urolind is a dietary supplement marketed by Germania Pharmazeutika in Austria, specifically formulated to support prostate health and normal bladder function. The product contains a combination of pumpkin seed extract (*Cucurbita pepo*), pomegranate extract (*Punica granatum*), and the trace element selenium. Pumpkin seed extract is traditionally utilized for its phytosterol content, which is believed to help manage symptoms of benign prostatic hyperplasia (BPH) and overactive bladder by modulating urinary tract function. Pomegranate extract provides antioxidant polyphenols, while selenium serves as a critical cofactor for antioxidant enzymes, protecting urogenital tissues from oxidative damage and supporting normal spermatogenesis. Urolind is available as an over-the-counter product in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Urolind.